Intensive Lipid Intervention in the Post-ENHANCE Era

O'Keefe, James H.; Bybee, Kevin A.; Lavie, Carl J.
August 2008
Mayo Clinic Proceedings;Aug2008, Vol. 83 Issue 8, p867
Academic Journal
The article discusses various report published within the issue, including one on the affects of high-dose atorvastatin versus low-dose atorvastatin in diabetic patients with coronary artery disease (CAD) and another on the analysis of various studies on the optimal treatment of hyperlipidemia.


Related Articles

  • Use of niacin in patients with diabetes. Taylor, James R. // Endocrine Today;Jun2010 Supplement, Vol. 8, p9 

    The article explains the use of niacin in patients with diabetes and hyperlipidemia.

  • Fibroblast growth factor 21: an overview from a clinical perspective. Rydén, Mikael // Cellular & Molecular Life Sciences;Jul2009, Vol. 66 Issue 13, p2067 

    Fibroblast growth factor 21 (FGF21) has been proposed as a novel putative therapeutic agent in type 2 diabetes. A large amount of data, predominantly obtained from murine models but also from non-human primates, suggest that FGF21 ameliorates obesity-associated hyperglycemia and hyperlipidemia...

  • EVALUATION OF ROLE OF ORAL ANTI-DIABETIC DRUGS ON LIPID PROFILE IN TYPE 2 DIABETES MELLITUS PATIENTS. Kumar, Nagendra; Kshitiz, Kshitish Kumar; Patra, Surajeet Kumar // International Journal of Pharma & Bio Sciences;Oct-Dec2010, Vol. 1 Issue 4, pP721 

    Diabetes mellitus is a group of metabolic disorder characterized by chronic hyperglycemia and disturbances of carbohydrate, fat and protein metabolism associated with absolute or relative insulin deficiency. The present study was carried out to establish a correlationship between hyperglycemia...

  • Hypertriglyceridaemia in diabetes. Smellie, W. Stuart A. // BMJ: British Medical Journal (International Edition);12/16/2006, Vol. 333 Issue 7581, p1257 

    The article explores two different cases of hypertriglyceridemia in patients with diabetes in order to highlight diagnosis and treatment of such in patients whose diabetes are badly controlled or newly presenting. The article presents the argument that before treating such patients with lipid...

  • Impact of Multiple Medication Use for Treatment of Diabetes and Lipid Disorders on Therapy Compliance, LDL, and HbA1c. Riedel, Aylin A.; Buysman, Erin K.; Arondekar, Bhakti; Horblyuk, Ruslan // Diabetes;Jun2007 Supplement 1, Vol. 56, pA553 

    We hypothesized that addition of Lipid Lower (LL) or Oral Antidiabetic (OAD) to current management for hyperlipidemia or diabetes could lead to reductions in compliance with prescribed medications and adverse outcomes. The purpose of this study was to assess the impact of addition of a second...

  • Evaluation of Medicago sativa L. sprouts as antihyperlipidemic and antihyperglycemic agent. Seida, Ahmed; El-Hefnawy, Hala; Abou-Hussein, Dina; Mokhtar, Fatma Alzahraa; Abdel-Naim, Ashraf // Pakistan Journal of Pharmaceutical Sciences;Nov2015, Vol. 28 Issue 6, p2061 

    Medicago sativa L. (Alfalfa) is traditionally used to treat diabetes. This study was designed to investigate the potential antihyperlipidemic and antihyperglycemic activity of M. sativa sprouts in streptozotocin (STZ) induced diabetes via i.p. injection of 55mg/kg of STZ. Experimental animals...

  • Clinical characteristics of patients with type 2 diabetes mellitus at the time of insulin initiation: INSTIGATE observational study in Spain. Costi, María; Dilla, Tatiana; Reviriego, Jesús; Castell, Conxa; Goday, Albert // Acta Diabetologica;Dec2010, Vol. 47, p169 

    Little information is available on the management of patients with type 2 diabetes mellitus (DM2) in regular clinical practice, prior to and at the point of initiating treatment with insulin. The INSTIGATE study provides a description of the clinical profile of the patient with DM2 who begins...

  • Trends in Publication of Evidence-based Traditional Iranian Medicine in Endocrinology and Metabolic Disorders. Hasani-Ranjbar, Shirin; Zahedi, Hoda Sadat; Abdollahi, Mohammad; Larijani, Bagher // Journal of Dental Medicine;2013, Vol. 26 Issue 4, p2 

    Traditional Iranian medicine (TIM) is a main part of complementary and alternative medicine (CAM). The popularity and use of alternative therapies are increasing due to adverse effects and ineffectiveness of pharmacologic treatments in some cases. Herbal medicine is one of the methods of...

  • Pioglitazone versus glimepiride on coronary artery calcium progression in patients with type 2 diabetes mellitus: a secondary end point of the CHICAGO study.  // Current Medical Literature: Cardiology;2010, Vol. 29 Issue 4, p110 

    The article compares the effectiveness of pioglitazone and glimepiride in treating type 2 diabetes patients in terms of coronary artery calcium (CAC) progression, as revealed in a published study in a 2010 edition of "Arteriosclerosis, Thrombosis and Vascular Biology." The study examined 299...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics